Delivery Order SPE2DB20D2104-SPE2DB25FMNXG
Award Date
4/18/25
Potential Completion Date
4/21/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,507.86, is a Firm Fixed Price Delivery Order to provide XELJANZ XR 11 MG TABLET prescription medication. The contract has an ultimate completion date of June 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,267.96 firm fixed-price delivery order is for the supply of XELJANZ 5 MG TABLET UU 60S, a medication. The contract has an ultimate completion date of June 5, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xeljanz 5 mg tablets. The $1,798.51 firm fixed-price delivery order is not set-aside and has a completion date of May 6, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,419.92 firm fixed-price delivery order is for the supply of Xeljanz 5 mg tablets, a prescription medication. The contract has an ultimate completion date of September 24, 2024. Amerisourcebergen, the prime contractor, does not have any set-aside designation for this award. This delivery order is placed against a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,411.89 delivery order contract is for the supply of the pharmaceutical product XELJANZ XR 11 MG TABLET. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 8, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,925.54 firm fixed-price delivery order is for the pharmaceutical product XELJANZ XR 11 MG TABLET UU 30S, with a performance period ending on May 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,273.04 firm fixed-price delivery order is for the supply of 4,568,040,659 units of the prescription medication XELJANZ 5 MG TABLET. The contract has an ultimate completion date of April 28, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $14,989.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xeljanz XR 11 mg tablets, a prescription medication, and is a firm fixed-price delivery order with an ultimate completion date of April 22, 2025. The contract is not set-aside and was awarded under Amerisourcebergen's existing Indefinite Delivery Contract...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. The contract is a $3,461.50 Firm Fixed Price Delivery Order with a completion date of June 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, with ID SPE2DB20D1047|SPE2DB25FF58A, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication XELJANZ 5 MG TABLET. The fixed-price delivery order, which is not set aside, has a ceiling value of $4,406.97 and a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...